why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat

Course: Antibody-Drug Conjugates and Adverse Events: Improving Identification and Management Among Oncology Nurses Serving Rural and Underserved Communities

CME Credits: 1.00

Released: 2025-06-02

The use of antibody-drug conjugates (ADCs) has greatly expanded in recent years due to promising outcomes in various cancer types. Despite their efficacy, ADCs are frequently associated with adverse events that require dose reductions, therapy interruptions, or discontinuation. As a result, oncology nurses play a central role in identifying, monitoring, and managing patients, particularly in rural and underserved communities that face oncologist shortages and limited access to multidisciplinary care. In this on-demand CE activity, expert faculty will review available ADC therapies, mechanisms that can cause clinical toxicity, and guidance for recognizing and managing common treatment-related adverse events. Strategies to enhance communication and improve education on ADC therapy among patients in rural and underserved communities will also be discussed. This enduring activity is a recorded session from Oncology Nursing Conference that took place on March 8, 2025.


Upon completion of this activity, participants should be better able to:


View Full Course